Citation: H. Yazici et al., INVESTIGATION OF THE MOLECULAR-CHANGES DURING CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA, Research communications in molecular pathology and pharmacology, 100(3), 1998, pp. 301-311
Authors:
CAY F
ONAT H
SAIP P
KARS A
DEMIRKAZIK A
AKBULUT H
KOCA S
AKYOL F
AKTAN G
FIRAT D
Citation: F. Cay et al., CISPLATIN AND EPIRUBICIN INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY IN LIMITED STAGE SMALL-CELL LUNG-CANCER (LS-SCLC), Annals of oncology, 9, 1998, pp. 502-502
Authors:
DEMIRKAZIK A
ONAT H
SAIP P
OZGUROGLU M
KARS A
CAY F
DEMIR G
UNER A
ARPACI F
AKTAN G
Citation: A. Demirkazik et al., HIGH-DOSE EPIRUBICIN AND CISPLATIN INDUCTION CHEMOTHERAPY SEQUENTIALLY FOLLOWED BY IFOSFAMIDE AND ETOPOSIDE CHEMOTHERAPY IN EXTENSIVE-STAGESMALL-CELL LUNG-CANCER (ES-SCLC), Annals of oncology, 9, 1998, pp. 505-505
Authors:
SAIP P
ONAT H
BASARAN M
TAS F
DEMIR C
UYGUN K
TOPUZ E
Citation: P. Saip et al., CLINICAL EFFICACY OF DIAZEPAM IN PROPHYLAXIS OF ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN-BASED CHEMOTHERAPY - A PROSPECTIVE RANDOMIZEDTRIAL, Annals of oncology, 9, 1998, pp. 701-701
Authors:
SAIP P
YASASEVER V
TENEKECI N
AYDINER A
INANC S
ONAT H
DISCI R
TOPUZ E
Citation: P. Saip et al., PREDICTION OF RADIOLOGICAL RESPONSE OF BONE METASTASES TO THERAPY BY BIOCHEMICAL MARKER MONITORING IN PATIENTS WITH BREAST-CANCER - A PRELIMINARY-STUDY, Journal of tumor marker oncology, 13(3), 1998, pp. 45-52
Authors:
TOPUZ E
SAIP P
AYDINER A
SALIHOGLU Y
BERKMAN S
BENGISU E
Citation: E. Topuz et al., INTRAPERITONEAL CISPLATIN-MITOXANTRONE AND INTRAVENOUS IFOSFAMIDE COMBINATION AS FIRST-LINE TREATMENT OF OVARIAN-CANCER, European journal of gynaecological oncology, 19(3), 1998, pp. 265-270
Authors:
TOPUZ E
SAIP P
AYDINER A
SALIHOGLU Y
YILMAZ T
TOPUZLU C
Citation: E. Topuz et al., CATHETER COMPLICATIONS ASSOCIATED WITH INTRAPERITONEAL CHEMOTHERAPY, European journal of gynaecological oncology, 19(3), 1998, pp. 275-279
Authors:
BERRAK E
ASLAY I
OZTURK N
DINCER M
AYDINER A
OZBILEN S
DISCI R
SAIP P
TOPUZ E
TORE G
Citation: E. Berrak et al., THE EFFECTS OF DIFFERENT TREATMENT MODELS ON TURKISH WOMEN WITH UTERINE SARCOMA, European journal of cancer, 33, 1997, pp. 943-943
Authors:
TOPUZ E
AYDINER A
SAIP P
BENGISU E
BERKMAN S
DISCI R
Citation: E. Topuz et al., INTRAPERITONEAL CISPLATIN - MITOXANTRONE IN OVARIAN-CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE, European journal of gynaecological oncology, 18(1), 1997, pp. 71-75